Association of serotonin receptor 2a haplotypes with obsessive–compulsive disorder and its treatment response in Iranian patients: a genetic and pharmacogenetic study
Marzie Sina,1 Abolhassan Ahmadiani,1 Sareh Asadi,2 Jamal Shams3 1Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2NeuroBiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 3Behavioral Sciences Research Center, Shahid Behe...
Guardado en:
Autores principales: | Sina M, Ahmadiani A, Asadi S, Shams J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f622276cd774c54ab06c275f91f6f49 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive–compulsive disorder
por: Hasanpour H, et al.
Publicado: (2018) -
Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
por: Najmeh Shahini, et al.
Publicado: (2021) -
Fluvoxamine treatment response prediction in obsessive-compulsive disorder: association rule mining approach
por: Hasanpour H, et al.
Publicado: (2019) -
Challenges in the Diagnosis and Assessment in Patients with Tourette Syndrome and Comorbid Obsessive-Compulsive Disorder
por: Szejko N, et al.
Publicado: (2021) -
Evaluating the Components of Alexithymia in Patients With Obsessive-Compulsive Disorder
por: Mina Bozorg, et al.
Publicado: (2021)